Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
2
×
cancer drugs
clinical trials
investing
2
×
ipo
life sciences
national blog main
sanofi
agios pharmaceuticals
amgen
cobimetinib
david e. shaw
deals
drug discovery
enasidenib
fda
ivosidenib
materials science
morphic
national top stories
new york
new york blog main
new york top stories
nimbus therapeutics
revolution medicines
roche
san francisco
san francisco blog main
san francisco top stories
schrödinger
software
takeda pharmaceutical
the bill & melinda gates foundation trust
the column group
third rock ventures
university of illinois
venture capital
What
ipo
medicines
2
×
cancer
company’s
course
despite
development
discover
drug
experimental
family
growing
handiwork
hardest
helped
hit
hottest
hunters
internal
landscape
pipeline
proteins
ras
reels
research
revolution
scan
schrödinger
schrödinger’s
sets
software
spot
support
targets
today
you’ll
Language
unset
Current search:
cancer
×
investing
×
medicines
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline